Artivion Inc. (AORT)
NYSE: AORTHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AORT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $886.02M
- Forward P/E
- 34.92
- EPS (TTM)
- -$0.36
- Dividend yield
- None
- Ex-dividend date
- Dec 9, 2015
- 52-week range
- 18.12 – 48.25
- Day range
- 18.13 – 18.93
- Volume / Avg
- 642.10K / 671.97K
- Beta
- —
- Shares outstanding
- 48.79M
52-week range
AORT stock today
On Nov 20, AORT ended the session at $18.16, shedding $0.37 (2.00%), versus the S&P 500's 3.70% decline. At this level, AORT sits near the bottom of its 52-week range of $18.12 to $48.25: 62.4% below the high, set on Dec 17, 2025 and 0.2% above the low. AORT is down 60.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 59.8%.
Artivion has posted a net loss over the last twelve months (EPS of -$0.36), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Artivion
Company profileArtivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. James Patrick Mackin
- Headquarters
- Kennesaw, GA
- Employees
- 1,800
- Website
- artivion.com
Financial highlights
Full financialsIn fiscal 2025, Artivion generated $441.3 million in revenue, up 13.6% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $9.8 million, for a net margin of 2.2% versus a median of -6.1% in the prior 5 years. Gross margin was 64.4% (up from 64.0%) and operating margin 7.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $441.33M | $388.54M | $354.00M | $313.79M | $298.84M |
| Growth | +13.59% | +9.75% | +12.82% | +5.00% | +18.01% |
| Net income | $9.77M | $-13.36M | $-30.69M | $-19.19M | $-14.83M |
| EPS (diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
Analyst forecast
ForecastConsensus (9 analysts)
strong_buy
Avg. price target
$38.47+111.84%
- Strong buy 2
- Buy 7
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.16 vs $0.11
- Surprise
- +45.45%
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $0.03
- Ex-dividend date
- Dec 9, 2015
AORT news
All AORT news- Artivion, Inc. Reports Third Quarter 2026 Financial Results and Narrows Full Year OutlookNasdaq
- Artivion (AORT) Q3 2026 Earnings Call TranscriptNasdaq
- Artivion Reports Third Quarter 2026 Financial ResultsPR Newswire
- Artivion to Participate in Upcoming Investor ConferencesPR Newswire
- Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial ResultsPR Newswire
- Why is Artivion stock rallying today?Investing.com
- Artivion rises as Jefferies initiates at buy, sees ’attractive entry point’Investing.com
- Steris (STE) Q1 Earnings Surpass EstimatesNasdaqSTE, AORT
Artivion peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KIDSOrthoPediatrics Corp. | 31.74 | -2.37% | $828.75M | vs AORT |
| VVVVvVARDIS Holding AG Class A | 14.55 | -3.00% | $770.91M | vs AORT |
| SGPSpyGlass Pharma Inc. | 30.43 | -1.14% | $1.02B | vs AORT |
| ATECAlphatec Holdings Inc. | 6.68 | -3.19% | $1.02B | vs AORT |
| IARTIntegra LifeSciences Holdings Corporation | 13.25 | -2.21% | $1.03B | vs AORT |
| IRMDiRadimed Corporation | 81.02 | -0.30% | $1.04B | vs AORT |
| BBNXBeta Bionics Inc. | 13.36 | +0.30% | $726.34M | vs AORT |
| SIBNSI-BONE Inc. | 23.73 | -0.08% | $1.07B | vs AORT |
Indexes, lists and sector
Artivion stock FAQ
What is Artivion's stock price today?
AORT last traded at $18.16 as of Nov 20, 4:00 PM EST, down 2.00% on the day. Prices are delayed at least 15 minutes.
Does Artivion pay a dividend?
Yes. Artivion pays $0.00 per share annually. The most recent dividend of $0.03 had an ex-dividend date of Dec 9, 2015.
Who is Artivion's CEO?
Mr. James Patrick Mackin is the chief executive officer of Artivion Inc., which has about 1,800 employees.
Has AORT ever split its stock?
Yes. The most recent AORT stock split was a 3-for-2 split on Dec 28, 2000, one of 2 splits on record.
What is the AORT 52-week high?
The 52-week high for AORT is $48.25 and the 52-week low is $18.12. The stock is currently 62.4% below its high.